The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial

• by Aiden V Brossfield, Donald J McMahon, Jason Fernando, Beatriz Omeragic, Rukshana Majeed, Sanchita Agarwal, Grazyna E Sroga, Bowen Wang, Deepak Vashishth, Mishaela R Rubin

• October 8, 2024

Depression, anxiety symptoms may be common in T1D

National survey data show a greater mental health symptom burden among adults with type 1 diabetes vs. those with type 2 diabetes or no diabetes.

• by Andrea Surnit

• October 19, 2026

• 4 min

Long-Term Satisfaction with the Choice to Complete Metabolic and Bariatric Surgery: The Hindsight 20/20 Study

• by Alexandra Burtea, Jaime Almandoz, Marielle Nagele, Sunil Mathew, Luyu Xie, Kathleen Esselink, Jeffrey Schellinger, Sarah Messiah, Ildiko Lingvay

• October 8, 2026

FDA approves first at-home therapy for thyroid eye disease

The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.

• by Mouj Hijazi

• October 16, 2026

• 2 min